Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.33T, Eli Lilly(LLY) trades at $1,413.43. The stock has a price-to-earnings ratio of 44.48 and currently yields dividends of 0.49%.
During the trading session on 2026-11-09, Eli Lilly(LLY) shares reached a daily high of $1,415.62 and a low of $1,350.00. At a current price of $1,413.43, the stock is +4.7% higher than the low and still -0.2% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.67M, versus its average volume of 3.46M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.
LLY News
U.S. pharmaceutical giant Eli Lilly (LLY) has announced that its obesity pill Foundayo has been found to significantly reduce the severity of sleep apnea. A lat...
Biotech ETFs face a pivotal week as Summit Therapeutics (NASDAQ:SMMT) approaches a key FDA decision, while fresh drug-development updates and Hims & Hers Health...
Eli Lilly releases Foundayo sleep apnea data Nov 09, 2026, 11:39 AM ET Eli Lilly and Company (LLY) Stock By : Jonathan Block, SA News Editor Eli Lilly ( LLY rfo...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly’s (LLY) stock is up 3% on Nov. 9 after Canada’s Drug Agency recommended that the cost of the company’s Kisunla (Donanemab) Alzheimer’s medication be r...
Eli Lilly (LLY -0.79%) and Novo Nordisk (NVO +0.03%) both participate in one of the biggest pharma growth markets today, and that's the weight loss drug market....
Eli Lilly (LLY -0.79%) is much loved on Wall Street because of its highly successful GLP-1 weight-loss business. Novo Nordisk (NVO +0.03%) is much less apprecia...
Eli Lilly and Hims & Hers Health announced a partnership in early November 2026 that lets eligible patients obtain Zepbound and Foundayo on the Hims & Hers tele...
After a 57% run-up over the past 52 weeks, Eli Lilly (LLY -0.79%) shares are expensive. The stock is now trading at 47 times trailing earnings. That's more than...
Eli Lilly's (LLY -0.79%) impressive run continues. The company's recent third-quarter update was excellent, sending the stock price up about 6%. Eli Lilly's wei...
Eli Lilly (NYSE:LLY) is partnering with Hims & Hers Health and LifeMD to offer FDA-approved obesity drugs through telehealth platforms. The collaborations give...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.